International Journal of Gerontology
Volume 3, Issue 4 , Pages 197-203, December 2009

Restless Legs Syndrome Among the Elderly

  • Pei-Hao Chen

      Affiliations

    • Department of Neurology, Mackay Memorial Hospital, Taipei, Taiwan
    • Mackay Medicine, Nursing and Management College, Taipei, Taiwan
    • ,
  • Shih-Jung Cheng

      Affiliations

    • Department of Neurology, Mackay Memorial Hospital, Taipei, Taiwan
    • Mackay Medicine, Nursing and Management College, Taipei, Taiwan
    • Corresponding Author InformationCorrespondence to: Dr Shih-Jung Cheng, Department of Neurology, Mackay Memorial Hospital, Main Branch, 92, Section 2, Chungshan North Road, Taipei, Taiwan

Accepted 1 December 2009.

Article Outline

Summary 

Restless legs syndrome is a sleep and movement disorder that affects 5–15% of the general population, with an increased prevalence among the elderly population. It not only affects quality of life but also increases risk of mortality among older adults. The diagnosis is based on clinical symptoms of the patient by four minimal essential criteria. Restless legs syndrome can be divided into primary or secondary causes. Examination should be performed to rule out potentially treatable illnesses, such as iron deficiency, renal failure or peripheral neuropathy, especially among elderly patients. The initial approach to restless legs syndrome should be nonpharmacologic management, such as good sleep hygiene, regular exercise, cognitive behavioral therapy and avoidance of certain aggravating drugs. An algorithm based on scientific evidence and expert opinion was developed for guidance of treatment. Combination or change of medication can be applied to resistant or difficult cases. Since elderly patients are prone to treatment-related side effects, the best strategy is to start medication cautiously and at the lowest recommended dosage.

Key Words:  anticonvulsants , diagnosis , dopamine agents , opioid , treatment

No full text is available. To read the body of this article, please view the PDF online.

 

Back to Article Outline

References 

  1. Trenkwalder C , Högl B , Winkelmann J . Recent advances in the diagnosis, genetics and treatment of restless legs syndrome . J Neurol . 2009;256:539–553
  2. Milligan SA , Chesson AL . Restless legs syndrome in the older adult: diagnosis and management . Drugs Aging . 2002;19:741–751
  3. Cuellar NG , Strumpf NE , Ratcliffe SJ . Symptoms of restless legs syndrome in older adults: outcomes on sleep quality, sleepiness, fatigue, depression, and quality of life . J Am Geriatr Soc . 2007;55:1387–1392
  4. Mallon L , Broman JE , Hetta J . Restless legs symptoms with sleepiness in relation to mortality: 20-year follow-up study of a middle-aged Swedish population . Psychiatry Clin Neurosci . 2008;62:457–463
  5. Allen RP , Picchietti D , Hening WA , et al.   Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health . Sleep Med . 2003;4:101–119
  6. Ferri R , Lanuzza B , Cosentino FI , et al.   A single question for the rapid screening of restless legs syndrome in the neurological clinical practice . Eur J Neurol . 2007;14:1016–1021
  7. Hening WA , Allen RP , Washburn M , et al.   The four diagnostic criteria for Restless Legs Syndrome are unable to exclude confounding conditions (“mimics”) . Sleep Med . 2009;10:976–981
  8. Allen RP , Walters AS , Montplaisir J , et al.   Restless legs syndrome prevalence and impact: REST general population study . Arch Intern Med . 2005;165:1286–1292
  9. Tsuboi Y , Imamura A , Sugimura M , et al.   Prevalence of restless legs syndrome in a Japanese elderly population . Parkinsonism Relat Disord . 2009;15:598–601
  10. Whittom S , Dauvilliers Y , Pennestri MH , et al.   Ageat-onset in restless legs syndrome: a clinical and polysomnographic study . Sleep Med . 2007;9:54–59
  11. Ondo WG . Restless legs syndrome . Neurol Clin . 2009;27:779–799 vii.
  12. Lee JE , Shin HW , Kim KS , et al.   Factors contributing to the development of restless legs syndrome in patients with Parkinson disease . Mov Disord . 2009;24:579–582
  13. O'Keeffe ST . Secondary causes of restless legs syndrome in older people . Age Ageing . 2005;34:349–352
  14. Wang J , O'Reilly B , Venkataraman R , et al.   Efficacy of oral iron in patients with restless legs syndrome and a low-normal ferritin: a randomized, double-blind, placebo-controlled study . Sleep Med . 2009;10:973–975
  15. Happe S , Vennemann M , Evers S , et al.   Treatment wish of individuals with known and unknown restless legs syndrome in the community . J Neurol . 2008;255:1365–1371
  16. Aukerman MM , Aukerman D , Bayard M , et al.   Exercise and restless legs syndrome: a randomized controlled trial . J Am Board Fam Med . 2006;19:487–493
  17. Hornyak M , Grossmann C , Kohnen R , et al.   Cognitive behavioral group therapy to improve patients scoping strategies with restless legs syndrome: a proof-of-concept trial . J Neurol Neurosurg Psychiatry . 2008;79:823–825
  18. Lettieri CJ , Eliasson AH . Pneumatic compression devices are an effective therapy for RLS: a prospective, randomized, double-blinded, sham-controlled trial . Chest . 2009;135:74–80
  19. Bayard M , Avonda T , Wadzinski J . Restless legs syndrome . Am Fam Physician . 2008;78:235–240
  20. Lee HB , Hening WA , Allen RP , et al.   Restless legs syndrome is associated with DSM-IV major depressive disorder and panic disorder in the community . J Neuropsychiatry Clin Neurosci . 2008;20:101–105
  21. Rottach KG , Schaner BM , Kirch MH , et al.   Restless legs syndrome as side effect of second generation antidepressants . J Psychiatr Res . 2008;43:70–75
  22. Kim SW , Shin IS , Kim JM , et al.   Bupropion may improve restless legs syndrome: a report of three cases . Clin Neuropharmacol . 2005;28:298–301
  23. Silber MH , Ehrenberg BL , Allen RP , et al.   An algorithm for the management of restless legs syndrome . Mayo Clin Proc . 2004;79:916–922
  24. Trenkwalder C , Hening WA , Montagna P , et al.   Treatment of restless legs syndrome: an evidence-based review and implications for clinical practice . Mov Disord . 2008;23:2267–2302
  25. Quilici S , Abrams KR , Nicolas A , et al.   Meta-analysis of the efficacy and tolerability of pramipexole versus ropinirole in the treatment of restless legs syndrome . Sleep Med . 2008;9:715–726
  26. von Spiczak S , Whone AL , Hammers A , et al.   The role of opioids in restless legs syndrome: an [11C]diprenorphine PET study . Brain . 2005;128:906–917
  27. Walters AS , Wagner ML , Hening WA , et al.   Successful treatment of the idiopathic restless legs syndrome in a randomized double-blind trial of oxycodone versus placebo . Sleep . 1993;16:327–332
  28. Kushida CA , Becker PM , Ellenbogen AL , et al.   Randomized, double-blind, placebo-controlled study of XP13512/GSK1838262 in patients with RLS . Neurology . 2009;72:439–446
  29. Thorp ML , Morris CD , Bagby SP . A crossover study of gabapentin in treatment of restless legs syndrome among hemodialysis patients . Am J Kidney Dis . 2001;38:104–108
  30. Winkelmann J , Stautner A , Samtleben W , et al.   Long-term course of restless legs syndrome in dialysis patients after kidney transplantation . Mov Disord . 2002;17:1072–1076
  31. García-Borreguero D , Allen RP , Benes H , et al.   Augmentation as a treatment complication of restless legs syndrome: concept and management . Mov Disord . 2007;22(Suppl 18):S476–S484
  32. Allen RP , Ritchie SY . Clinical efficacy of ropinirole for restless legs syndrome is not affected by age at symptom onset . Sleep Med . 2008;9:899–902
  33. Walters AS , Winkelmann J , Trenkwalder C , et al.   Long-term follow-up on restless legs syndrome patients treated with opioids . Mov Disord . 2001;16:1105–1109

PII: S1873-9598(10)70001-6

doi:10.1016/S1873-9598(10)70001-6

International Journal of Gerontology
Volume 3, Issue 4 , Pages 197-203, December 2009

Article Tools